Sign in
IRD Stock Price, Chart, Stats & News
Opus Genetics, Inc.
Save
Opus Genetics, Inc. (IRD) does not currently pay a dividend.
313.75M
Market cap
–
Current P/E
12.00x
Forward P/E
IRD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 57.40% |
Operating margin | -271.90% |
Pretax margin | -349.33% |
Net margin | -349.33% |
Effective tax rate | – |
ROA | -98.70% |
ROE | -452.26% |
D/E | – |
Interest coverage ratio | -26.33x |
IRD valuation
P/E | – |
P/S | 21.80x |
P/B | 176.35x |
P/CF | -76.78x |
P/FCF | -8.78x |
P/OCF | -76.78x |
PEG | -1.02x |
EV multiple | -7.97x |
About
Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation).
Similar securities
Based on sector and market capitalization
Report issue